Latest return on equity
Neuphoria Therapeutics Return on equity
Direct answer
Neuphoria Therapeutics's return on equity is -61.7%.
The verified market snapshot reports -61.7%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 6, 2026.
Get free Neuphoria Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -61.7%
Explore related company data
View Neuphoria Therapeutics's market capitalizationView Neuphoria Therapeutics's price-to-book ratioView Neuphoria Therapeutics's dividend yieldView Neuphoria Therapeutics's 52-week price rangeView Neuphoria Therapeutics's profit marginView Neuphoria Therapeutics's debt-to-equity ratioView all Neuphoria Therapeutics key metricsReturn to Neuphoria Therapeutics profile